Covered recipient · General Payments record
TERESA ASHLEY MOLL
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2021–2024
$2,450.91
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $618.90 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $120.69 | 1 |
| Amgen Inc. | $98.16 | 5 |
| Abbott Laboratories | $90.68 | 5 |
| DEXCOM, INC. | $83.32 | 3 |
| Kyowa Kirin, Inc. | $50.41 | 2 |
| SANOFI-AVENTIS U.S. LLC | $45.75 | 2 |
| Medtronic, Inc. | $43.45 | 3 |
| Xeris Pharmaceuticals, Inc. | $25.74 | 1 |
| Novo Nordisk AS | $23.87 | 1 |
| Insulet Corporation | $21.40 | 1 |
| Tandem Diabetes Care, Inc. | $15.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.70 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124953498 | CMS |
| Abbott Laboratories | $17.17 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124953502 | CMS |
| Abbott Laboratories | $17.66 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124953506 | CMS |
| Abbott Laboratories | $21.60 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124953509 | CMS |
| Abbott Laboratories | $13.55 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124953513 | CMS |
| Amgen Inc. | $20.53 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115940139 | CMS |
| Amgen Inc. | $29.63 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115940145 | CMS |
| Amgen Inc. | $15.56 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115940151 | CMS |
| Amgen Inc. | $18.27 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115940158 | CMS |
| Amgen Inc. | $14.17 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115940164 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $120.69 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117946791 | CMS |
| Dexcom, Inc. | $30.75 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153340099 | CMS |
| Dexcom, Inc. | $30.36 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153340101 | CMS |
| Dexcom, Inc. | $22.21 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153340103 | CMS |
| Insulet Corporation | $21.40 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116805340 | CMS |
| Kyowa Kirin, Inc. | $24.19 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127044533 | CMS |
| Kyowa Kirin, Inc. | $26.22 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127044535 | CMS |
| Medtronic, Inc. | $14.46 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117143219 | CMS |
| Medtronic, Inc. | $15.15 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117143221 | CMS |
| Medtronic, Inc. | $13.84 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117143223 | CMS |
| Novo Nordisk Inc | $23.87 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097510546 | CMS |
| SANOFI-AVENTIS U.S. LLC | $23.78 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140009212 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.97 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140009230 | CMS |
| Tandem Diabetes Care, Inc. | $15.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138740843 | CMS |
| Xeris Pharmaceuticals, Inc. | $25.74 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144615395 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.